A Phase III, Double-Blind, Randomized, Active Controlled, Monotherapy Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes Mellitus
Phase of Trial: Phase III
Latest Information Update: 23 Apr 2013
At a glance
- Drugs Ipragliflozin (Primary) ; Acarbose
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 01 Oct 2012 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 05 Sep 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.